160 results
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
the Company nor any Subsidiary is in default with respect to any Indebtedness.
(bb) Tax Status. Except for matters that would not, individually … United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction
6-K
EX-10.2
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.. Subject to payment
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
by the Custodian or the Depositary. If the Depositary determines that any distribution in cash or property is subject to any tax or governmental charges … used in currency conversions is available upon request.
Liability of Holders for Taxes, Duties or Other Charges
Any tax or other governmental charge
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
may be a passive foreign investment company, or PFIC, for U.S. federal income tax purposes for our taxable year ending December 31, 2023 or in any … subsequent year. There may be negative tax consequences for U.S. taxpayers that are holders of our ordinary shares or our ADSs if we are a PFIC.
We
F-3
13hy5xf9 ylgbcian0mr
29 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-99
sptsu9avy47xodi2k
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
ythodzqz3s9cj of
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
dvqo6d5b
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-10.2
gstc9000o80h
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.1
nnmzqe0
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.3
623j6k9f pi9ag5hz4
21 Sep 22
Current report (foreign)
8:00am
424B5
ufm7hv9 1qx67qr
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
05dp8 g69m
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
cwx 4byj4lk902
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am